Strategic Global Advisors’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
Strategic Global Advisors's BMY Position: Q2 2025 in Review
Strategic Global Advisors sold out of Bristol-Myers Squibb (BMY) in Q2 2025, closing a stake of 40,222 shares — an estimated $2.45M sold.
Strategic Global Advisors first reported a position in BMY in Q2 2021 and held it in 16 quarters. The position peaked at $16.8M in Q2 2022. 2,292 funds tracked by Wall St. Rank hold BMY as of Q2 2025.
- Strategic Global Advisors reported no remaining Bristol-Myers Squibb position as of Q2 2025 after selling out during the quarter.
- Strategic Global Advisors sold 40,222 Bristol-Myers Squibb shares in Q2 2025, an estimated $2.45M.
- Strategic Global Advisors first reported a position in Bristol-Myers Squibb in Q2 2021 and held it in 16 quarters.
- Strategic Global Advisors's Bristol-Myers Squibb position peaked at $16.8M in Q2 2022.
- 2,292 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2025.
Based on Strategic Global Advisors's 13F filing for Q2 2025, filed 14 Aug 2025.